Quick summary
  • If you have a family history of breast cancer, the right screening plan depends on your age, symptoms, breast density, the number of affected relatives, their age at diagnosis, and whether a known inherited gene mutation is present.
  • Mammography remains the main breast screening test for many women. Breast ultrasound is useful for breast lumps, focal pain, dense breast tissue and targeted assessment. Breast MRI is often used for very high-risk patients, especially those with BRCA1, BRCA2, PALB2 or TP53 mutations.

Family History of Breast Cancer: What It Means and Which Screening Tests You May Need

When your GP or a breast specialist asks about your family history, they are talking about your blood relatives, not in‑laws or close friends.

This includes both sides of the family, your mother’s side and your father’s side. Parents, brothers and sisters, children, grandparents, aunts, uncles, cousins, nieces and nephews can all be relevant.

It is easy to assume that only the women in the family “count”, but that is not accurate since male relatives matter too.

A father, brother or uncle with breast cancer is important to flag clearly because breast cancer in men is rare and can point to an inherited gene change running through the family.

And the timing also matters. If one relative was diagnosed later in life, say in their sixties or seventies, and no one else in the family has had breast or ovarian cancer, your risk is usually only slightly higher than average.

The picture changes when several relatives are affected, when diagnoses happen at a younger age, or when breast and ovarian cancers show up across different branches of the same family. These patterns are what move someone from near‑population risk into a moderate or high‑risk group.

We’re going into detail about this in this article and everything you need to know about family history of breast cancer and what you need to do in that case.

How much does family history raise your breast cancer risk?

Having a relative with breast cancer changes your odds. It does not decide them.

Large UK studies show that women with a first‑degree relative, meaning a mother, sister or daughter, with breast cancer have roughly double the risk of women with no affected first‑degree relatives.

While the number can sound alarming, it is important to know that even in this higher risk group, most women still go through life without ever developing breast cancer.

Your risk tends to rise further when:

  • Two or more close relatives are affected
  • A relative was diagnosed before about age 40 to 50
  • A male relative has had breast cancer
  • Breast and ovarian cancers both appear in the same branch of the family
  • A relative carries a known high‑risk gene change such as BRCA1 or BRCA2

Because these patterns can get complicated once you add cousins, half‑siblings and relatives on your father’s side, UK breast clinics rarely rely on one relative’s story alone.

Instead, they use structured family history questionnaires alongside breast cancer risk calculators, such as Tyrer‑Cuzick or BOADICEA/CanRisk, to work out an estimated lifetime risk.

These tools take into account how many relatives are affected, the ages at diagnosis, your own hormonal and reproductive history and sometimes breast density. The result is a personalised risk estimate rather than a rough guess.

Why Breast Cancer Can Run in Families: Family history and breast cancer genes

Why breast cancer can run in families infographic
Why Breast Cancer Can Run in Families: Family history and breast cancer genes

In most families, breast cancer develops from a combination of ageing, hormone exposure, breast density and lifestyle factors, rather than a single gene fault.

A smaller group of families carry inherited changes in genes that normally help cells repair damaged DNA. The most well‑known include:

  • BRCA1 and BRCA2, high‑risk genes that significantly raise the chance of breast and ovarian cancer and can be linked to other cancers as well.
  • PALB2, which works with BRCA2 in DNA repair. Some PALB2 changes can push lifetime breast cancer risk into a similar range as BRCA2.
  • TP53, linked to Li‑Fraumeni syndrome, a rare condition associated with several early‑onset cancers including breast cancer.
  • CHEK2, ATM and other moderate‑risk genes that can contribute to clusters of breast cancer in families, usually with lower risk than BRCA1 or BRCA2.

If a gene change like BRCA runs in a family, not every relative will inherit it.

Genetic testing is what tells the difference between a person who truly carries a high‑risk gene and someone whose inherited risk is closer to the general population.

It’s also important to know that genetic testing is not automatically offered just because one relative has had breast cancer.

It is usually recommended when the overall pattern in the family points clearly towards an inherited cause: early diagnoses, several affected relatives, male breast cancer or a combination of breast and ovarian cancers.

Knowing your family history helps you and your clinician decide how closely to watch for changes, but it isn’t a substitute for getting a current symptom checked properly.

If you’ve noticed a lump, a nipple change, breast pain, a skin change, or anything else that feels different right now, the One Stop Breast Clinic is built to get you a clear answer without unnecessary delay.

Book the One Stop Breast Clinic – £949

Book the One Stop Breast Clinic – £949

Near‑population, moderate and high‑risk groups: Why the difference matters

To make sense of different family patterns, UK breast and genetics clinics group people into three main categories: near‑population risk, moderate risk and high risk.

Near‑population (or “general”) risk

This usually applies if you have one female relative over 40 with breast cancer, with no male breast cancer, no ovarian cancer and no clear clustering. Your risk sits close to that of the general population for your age. Current NHS breast screening guidance offers mammograms every three years between 50 and 70 in this group.

Moderate familial risk

This group includes a modest cluster, for example two close relatives with breast cancer diagnosed at typical ages, or one relative with breast cancer plus a limited number of related cancers. Lifetime risk is higher than average, but it is still more likely than not that you will never develop breast cancer. Women in this category are often offered earlier or more frequent mammograms, for example yearly from about 40 to 49.

High or very high risk

This applies when there is strong clustering across the family, early diagnoses, male breast cancer, both breast and ovarian cancers, bilateral breast cancer (cancer in both breasts), or a confirmed high‑risk gene mutation such as BRCA1, BRCA2, PALB2 or TP53. Lifetime risk in this group can be several times higher than the general population.

Annual mammography and sometimes MRI may be recommended from a younger age, alongside conversations about risk‑reducing medication and, in some cases, surgery.

Being placed into a moderate or high‑risk group is not a diagnosis and it does not mean breast cancer is on its way. It means your team has enough information to build a screening and monitoring plan that matches your real risk rather than leaving things to chance.

Which Screening tests are used for a woman with a family history of breast cancer?

Screening tests for women with a family history of breast cancer
Screening tests for women with family history of breast cancer

The main breast screening and diagnostic tools include mammography, breast ultrasound, breast MRI, genetic counselling and testing, clinical breast examination, and biopsy if an abnormality is found.

Mammograms

Mammograms are low‑dose X‑rays of the breast and remain the core tool for breast cancer screening, including for women with a family history. In the general NHS Breast Screening Programme, women are invited every three years between 50 and 70. If your family history places you in a moderate or high‑risk group, you may be offered mammograms earlier, often from around 40, and more frequently.

Mammograms are particularly good at picking up tiny areas of calcification and subtle changes in breast tissue that can appear before a lump is felt.

Breast ultrasound

Breast ultrasound uses sound waves rather than radiation and works best when there is a specific area to look at. It can:

  • Tell the difference between a fluid‑filled cyst and a solid lump
  • Give a clearer view of dense breast tissue, which can be harder to read on mammograms
  • Investigate localised breast pain or tenderness
  • Check lymph nodes in the armpit
  • Guide a needle biopsy when one is needed

For women with a family history of breast cancer, ultrasound is usually used alongside mammography rather than on its own, especially when there is a symptom or an unclear mammogram result. It tends to be particularly useful in younger women, whose breasts are often denser.

Both breasts is the option most people choose when the reason for scanning is family history rather than a single-sided symptom, since it gives a side-by-side comparison and covers both axillae in one visit.

If a breast ultrasound is the right next step for you, booking is direct at LondonSono with no GP referral needed.

Book Your Breast Ultrasound Scan

Book Your Breast Ultrasound Scan

Breast MRI

Breast MRI uses magnetic fields and contrast dye to produce highly detailed images and can be more sensitive than mammography or ultrasound for certain high‑risk groups.

Annual MRI is usually reserved for situations such as:

  • BRCA1 or BRCA2 mutation carriers
  • Some women with PALB2 or TP53 mutations
  • Those with very strong family histories and a high calculated lifetime risk
  • Women who had chest radiotherapy at a young age

Because MRI is so sensitive, it can also pick up benign changes that still need follow‑up. For that reason, it is used inside defined high‑risk protocols rather than offered to everyone as an extra reassurance scan.

Is Breast Ultrasound a Screening Test for Family History?

Breast ultrasound can be helpful, but it should not usually be seen as a replacement for mammography or MRI in high-risk screening.

Ultrasound is excellent for looking at a specific area of concern and for assessing dense breast tissue, but it may miss certain early cancers, especially microcalcifications, which are better detected by mammography.

For high-risk women, MRI is often the preferred additional screening test because it is more sensitive for detecting early breast cancer in genetically high-risk groups.

The safest wording is: breast ultrasound can be a valuable additional assessment tool, but women with a strong family history should also follow formal breast screening and genetic risk guidance.

Genetic testing – who should consider it?

Genetic testing is not needed for everyone who has one relative with breast cancer. It is most useful when the overall family pattern suggests inherited risk.

You may benefit from genetic counselling if there is:

  • Breast cancer diagnosed under about 40 or 50 in a close relative
  • Several relatives with breast cancer on the same side of the family
  • Ovarian cancer in the family
  • Male breast cancer
  • Triple‑negative breast cancer at a young age
  • Bilateral breast cancer (cancer in both breasts)
  • A known BRCA or other gene mutation in the family
  • Breast cancer plus pancreatic or aggressive prostate cancer in close relatives

A genetic counsellor can help decide whether testing is appropriate and explain what the results could mean for you and your relatives.

What if genetic testing is negative?

A negative result can be reassuring, but it has to be interpreted in the context of your family.

If a known family mutation exists and you test negative for that mutation, your inherited risk from that gene is much lower and may move closer to the general population level.

If no affected relative has been tested, a negative result is harder to interpret. Some families have clusters of breast cancer without a currently identifiable gene change. That is why genetic testing should be ordered and explained by trained professionals.

In all cases, your personal screening plan should be based on both your test result and your wider family history, not on one piece of information alone.

The triple assessment pathway

For people with breast symptoms or concerning findings, many clinics use a structured “triple assessment” approach to make sure nothing important is missed.

Triple assessment usually includes:

  • Clinical assessment: a breast specialist listens to your symptoms and examines your breasts and armpits.
  • Imaging: ultrasound, mammography or both, depending on your age and what the examination shows.
  • Biopsy: if imaging finds a suspicious area, a small tissue sample is taken to confirm whether it is benign or cancerous.

Triple assessment is a safe, proven way to investigate breast symptoms. Some clinics offer a one‑stop appointment where all three steps can happen on the same day, so you leave with a clear plan rather than a long wait for answers.

If you have a breast symptom rather than just a family history concern, this is the pathway built for exactly that: one coordinated appointment instead of separate referrals and waiting.

The One Stop Breast Clinic brings the full triple assessment together: clinical examination with a Consultant Breast Surgeon, bilateral breast and axilla ultrasound, and mammography, with biopsy arranged separately only if the findings need it.

Book the One Stop Breast Clinic (Triple Assessment)

Book the One Stop Breast Clinic (Triple Assessment)

When to start mammograms if you have a family history

You may have heard the rule of “ten years before your mum’s diagnosis”. More recent research suggests a more tailored approach.

Studies indicate that if your closest affected relative was diagnosed at or before 45, starting mammograms about five to eight years earlier than their diagnosis age can bring your risk roughly in line with an average‑risk 50‑year‑old woman, which is the age NHS screening usually starts.

In practical terms, if your mother was diagnosed at 42, you and your doctor might discuss starting mammograms somewhere between 34 and 37. If she was diagnosed at 55, starting screening at the usual NHS age may well be enough unless you have other risk factors.

In the UK, decisions about start age and frequency are usually based on a formal assessment at a family history or genetics clinic rather than a fixed rule. Specialists look at your whole family picture and your own history before recommending a screening timetable.

If your current plan does not feel like it reflects your family history, that is a good reason to ask your GP about referral.

Breast screening by age and risk

Breast screening by age and risk
Age groupTypical imaging approachKey points
Under 30Ultrasound as first-line test for lumpsBreast cancer is uncommon but symptoms still need assessment. Breast tissue is often dense, so mammograms can be harder to interpret.
30–39Ultrasound, mammography or MRI depending on symptomsSymptomatic women may have different tests based on clinical judgement. Strong family history should trigger formal risk assessment rather than relying only on routine screening.
40–49Earlier or more frequent mammograms in higher-risk womenWomen with moderate or high familial risk may be offered annual or more frequent imaging, guided by their family history and risk calculator scores.
50–70Routine NHS mammograms every 3 yearsThis is the usual screening age range. Women at higher risk may need extra imaging or shorter intervals between screens.
Over 70Mammograms on requestAutomatic invitations stop, but women can usually request NHS screening. At any age, new symptoms should be assessed rather than waiting for routine screening.
Any age with symptomsDiagnostic imaging (usually triple assessment)Screening is for people without symptoms. New lumps, nipple changes or skin changes should be investigated through a breast clinic, often using clinical exam, imaging and biopsy.

Red‑flag symptoms to get checked

Family history is important, but new symptoms are even more important. Screening is meant for people who feel well. It does not replace seeing a doctor if something changes.

Speak to your GP promptly if you notice:

  • A new lump in your breast
  • A lump or persistent fullness in your armpit
  • Blood‑stained or unexplained nipple discharge
  • New nipple inversion or a clear change in nipple shape
  • Skin dimpling or a texture that looks like orange peel
  • Persistent redness or thickening of the breast skin
  • Breast pain in one spot that does not settle over a couple of cycles
  • Any sudden change in breast size or shape that feels unusual for you

If you have any of these symptoms, you should be referred to a symptomatic breast clinic. There you may have a mammogram, ultrasound and possibly a biopsy. Your family history can then help guide which tests you have and how you are followed up afterwards.

Book a Private Breast Ultrasound Appointment in London

A family history of breast cancer can understandably create worry, but it is more useful as a starting point for a personalised plan than as a reason to panic.

Your best screening pathway depends on your age, symptoms, breast density, the pattern of cancers in your family and whether any known gene mutation is present. For many women, mammography remains the foundation of screening, with ultrasound added for symptoms and dense tissue and MRI reserved for higher‑risk situations.

At London Private Ultrasound, you can access private breast ultrasound and one‑stop breast clinic pathways if you have symptoms, dense breast tissue, a family history concern or simply want reassurance alongside NHS screening.

Appointments typically include targeted breast and axilla (armpit) ultrasound, Doppler assessment when it helps, a clear written report, and an explanation of the findings in plain language.

Where needed, you can be guided onto appropriate mammography, breast surgeon review or further hospital‑based investigation, so your private imaging fits smoothly into a wider care plan rather than sitting on its own.

Book a breast ultrasound consultation today.

Book a breast ultrasound consultation today

Frequently asked questions

Do I need a mammogram earlier than 50 if my mum had breast cancer?

Possibly, but it depends on your full family picture, not just your mum. Some studies suggest that starting five to eight years earlier than your closest relative’s diagnosis age can make sense when that diagnosis was before 45. In the UK, the practical step is to ask for referral to a family history or genetics clinic, so your risk can be calculated, and a personalised start age and interval agreed.

What if you test positive for BRCA1 or BRCA2?

A positive BRCA result means you have inherited a gene change that increases your chance of certain cancers. It does not mean you currently have cancer.

If you test positive, your care may include:

  • Earlier and more frequent breast screening
  • Annual MRI in high‑risk programmes
  • Mammography adapted to your age and risk group
  • Risk‑reducing medication in selected cases
  • Discussion of risk‑reducing breast or ovarian surgery if appropriate
  • A plan for managing ovarian cancer risk
  • Offering testing to close relatives who may also carry the same gene change

Is breast ultrasound enough on its own if I have dense breasts and a family history?

Ultrasound is excellent for investigating specific areas and dense tissue, but it does not fully replace mammography. Mammograms are better at picking up some early changes, such as microcalcifications. Most high‑risk screening plans combine mammography with MRI for selected women and use ultrasound mainly for symptoms and follow‑up scans.

Does a family history on my father’s side count?

Yes. Inherited gene changes can be passed down from fathers as well as mothers, so breast and ovarian cancers on your father’s side, and male relatives with breast cancer, are just as important in risk assessment as those on your mother’s side.

References & clinical review

This article is intended for general patient information only and does not replace personalised medical advice, genetic counselling or formal breast-risk assessment. New breast symptoms should be assessed promptly rather than waiting for routine screening.

PA
Mr Pedram AghaeiMedical Writer & Commercial Director

MSc Vascular Ultrasound · MSc Medical Ultrasound. Co-founder of London Private Ultrasound. Pedram leads the clinic’s medical writing and editorial governance.

View profile →

HR
Mrs Hosna RashidiUltrasound Consultant

Ultrasound Consultant with extensive diagnostic ultrasound and clinical training experience. Hosna reviews patient-facing clinical content for accuracy.